• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.

作者信息

Herrou Julia, De Lastours Victoire

机构信息

Department of Medicine, Beaujon University Hospital, Clichy, France

Department of Medicine, Beaujon University Hospital, Clichy, France.

出版信息

Ann Rheum Dis. 2020 Feb;79(2):e23. doi: 10.1136/annrheumdis-2018-214718. Epub 2018 Nov 28.

DOI:10.1136/annrheumdis-2018-214718
PMID:30487148
Abstract
摘要

相似文献

1
Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.长期大剂量使用糖皮质激素的风湿性疾病患者发生肺孢子菌肺炎的预测因素。
Ann Rheum Dis. 2020 Feb;79(2):e23. doi: 10.1136/annrheumdis-2018-214718. Epub 2018 Nov 28.
2
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.长期大剂量应用糖皮质激素的风湿性疾病患者中，复方磺胺甲噁唑对预防卡氏肺孢子虫肺炎的作用。
Ann Rheum Dis. 2018 May;77(5):644-649. doi: 10.1136/annrheumdis-2017-211796. Epub 2017 Nov 1.
3
Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.肺孢子菌与糖皮质激素的使用：预防性用药与否（以及何时用药）；这是个问题。
Ann Rheum Dis. 2018 May;77(5):631-633. doi: 10.1136/annrheumdis-2017-212588. Epub 2018 Feb 19.
4
Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.风湿性疾病患者长期接受非大剂量类固醇治疗时的卡氏肺囊虫肺炎-复方磺胺甲噁唑作为原发性预防的临床意义。
Arthritis Res Ther. 2019 Sep 14;21(1):207. doi: 10.1186/s13075-019-1996-6.
5
Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.低剂量磺胺甲恶唑/甲氧苄啶治疗系统性风湿性疾病患者耶氏肺孢子菌肺炎的有效性和安全性：一项回顾性多中心研究。
J Infect Chemother. 2019 Apr;25(4):253-261. doi: 10.1016/j.jiac.2018.11.014. Epub 2019 Jan 12.
6
Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in patients with systemic rheumatic diseases receiving moderate-to high-dose glucocorticoids.中剂量至大剂量糖皮质激素治疗的系统性风湿病患者采用小剂量复方磺胺甲噁唑预防卡氏肺孢子虫肺炎的有效性和安全性。
Respir Investig. 2024 Nov;62(6):1195-1201. doi: 10.1016/j.resinv.2024.10.007. Epub 2024 Oct 22.
7
Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?对于所有风湿性疾病患者，我们能否毫无顾虑地开具复方磺胺甲恶唑预防性用药处方？
Ann Rheum Dis. 2019 Feb;78(2):e17. doi: 10.1136/annrheumdis-2018-213027. Epub 2018 Feb 6.
8
Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids.甲氧苄啶-磺胺甲恶唑与阿托伐醌在接受长期大剂量糖皮质激素治疗的结缔组织病患者中预防肺孢子菌肺炎的比较疗效
Rheumatol Int. 2022 Aug;42(8):1403-1409. doi: 10.1007/s00296-021-04945-w. Epub 2021 Jul 14.
9
Reduction of pneumonia and bloodstream infections by trimethoprim-sulfamethoxazole prophylaxis in patients with rheumatic diseases.甲氧苄啶-磺胺甲恶唑预防性用药对风湿性疾病患者肺炎和血流感染的减少作用
Scand J Rheumatol. 2021 Sep;50(5):365-371. doi: 10.1080/03009742.2020.1850854. Epub 2021 Mar 22.
10
High-dose trimethoprim-sulfamethoxazole therapy with corticosteroids in previously intolerant patients with AIDS-associated Pneumocystis carinii pneumonia.对先前不耐受的艾滋病相关卡氏肺孢子虫肺炎患者采用高剂量甲氧苄啶-磺胺甲恶唑联合皮质类固醇治疗。
Arch Dermatol. 1999 Mar;135(3):350-1. doi: 10.1001/archderm.135.3.350.

引用本文的文献

1
Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii Pneumonia in critically pediatric patients.宏基因组下一代测序在儿童危重症患者肺孢子菌肺炎诊断中的应用。
Ann Clin Microbiol Antimicrob. 2023 Jan 16;22(1):6. doi: 10.1186/s12941-023-00555-5.
2
Rates of Pneumocystis jirovecii pneumonia and prophylaxis prescribing patterns in a large electronic health record cohort of patients with systemic lupus erythematosus.在一个大型电子健康记录队列的系统性红斑狼疮患者中，肺孢子菌肺炎的发生率和预防用药模式。
Semin Arthritis Rheum. 2022 Dec;57:152106. doi: 10.1016/j.semarthrit.2022.152106. Epub 2022 Oct 17.
3
Detection of Pneumonia in Infants with Non-Human Immunodeficiency Virus Admitted to Pediatric Intensive Care Using Metagenomics Next-Generation Sequencing.
使用宏基因组学下一代测序技术检测入住儿科重症监护病房的非人类免疫缺陷病毒感染婴儿的肺炎情况。
Infect Drug Resist. 2022 Apr 16;15:1889-1902. doi: 10.2147/IDR.S358483. eCollection 2022.
4
High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center.抗 MDA5 抗体阳性皮肌炎患者中肺孢子菌感染的高发生率和死亡率：来自单中心的经验。
Arthritis Res Ther. 2021 Sep 4;23(1):232. doi: 10.1186/s13075-021-02606-8.
5
Prevention of complications from use of conventional immunosuppressants: a critical review.常规免疫抑制剂使用相关并发症的预防：批判性综述。
J Nephrol. 2019 Dec;32(6):851-870. doi: 10.1007/s40620-019-00602-5. Epub 2019 Mar 29.